KrISS feed 8.11
- Un simple et superbe (ou stupide) lecteur de flux. Par
Tontof
-
Jan 07, 2023
-
The Japan Times (No Author)
-
lire
Bomb threat prompts plane’s emergency landing at Chubu Airport
Investigators said a phone call from Germany had been received around 6:20 a.m., with a man claiming to have put 100 kilograms of plastic explosives ...
-
Jan 07, 2023
-
The Japan Times (No Author)
-
lire
After bitter intraparty dispute, McCarthy named U.S. House speaker
The California Republican's victory after a week of repeated votes has highlighted divisions within the party and raised questions about their ability to govern.
-
Jan 07, 2023
-
The Japan Times (No Author)
-
lire
China in talks with Pfizer for generic COVID drug
Beijing is in talks with the drugmaker to secure a license that will allow domestic firms to manufacture and distribute a generic version of its ...
-
Jan 07, 2023
-
The Japan Times (No Author)
-
lire
International fusion energy project faces delays, chief says
A 2025 deadline "wasn't realistic in the first place," even before two major problems surfaced, the International Thermonuclear Experimental Reactor head said.
-
Jan 07, 2023
-
The Japan Times (No Author)
-
lire
‘What cease-fire?’ Shells fly at Ukraine front despite Putin’s truce.
Russian and Ukrainian forces exchanged artillery fire at the front line in Ukraine on Friday, even after Moscow said it had ordered its troops to ...
-
Jan 07, 2023
-
The Japan Times (No Author)
-
lire
Billionaire Jack Ma gives up control of Ant Group
The company will give 10 individuals, including the founder, management and staff, voting rights independently, effectively removing Ma’s voting control of Ant.
-
Jan 07, 2023
-
The Japan Times (Peter Martin)
-
lire
The U.S. keeps offering China its COVID vaccines. China keeps saying no.
China has rebuffed repeated offers to share advanced vaccines as it battles a COVID-19 wave, a rejection that’s frustrated American officials concerned about a resurgence ...
-
Jan 07, 2023
-
The Japan Times (No Author)
-
lire
Alzheimer’s drug made jointly by Japan’s Eisai wins accelerated U.S. approval
The U.S. has called the drug "an important advancement in the ongoing fight" against the debilitating disease. But it's $26,000 price tag could put it ...
-
Jan 07, 2023
-
The Japan Times (No Author)
-
lire
China’s deep-pocketed tourists are staying home, for now
The $280 billion force that is Chinese tourism may not reemerge for months, thanks to lingering infections, restrictions for new arrivals and surging costs.
-
Jan 07, 2023
-
The Japan Times (Kari Lindberg)
-
lire
U.S. Navy cuts Taiwan transits even as China steps up military pressure
The U.S. reduced its number of naval transits through the Taiwan Strait in 2022 to the lowest level in four years.